APO N150 Pill - red capsule/oblong
Pill with imprint APO N150 is Red, Capsule/Oblong and has been identified as Nilotinib 150 mg. It is supplied by Apotex Corp.
Nilotinib is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Nilotinib 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for APO N150
Nilotinib
- Imprint
- APO N150
- Strength
- 150 mg
- Color
- Red (red opaque body and red opaque cap)
- Shape
- Capsule/Oblong (hard gelatin capsule)
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Apotex Corp.
- National Drug Code (NDC)
- 60505-3801
Related images for "APO N150"
More about nilotinib
- Check interactions
- Compare alternatives
- Reviews (40)
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.